The present study evaluates the effectiveness of ADHD treatment and the utility of QbCheck in a remote setting. It tests whether improvements in objective ADHD metrics are associated with improvements in patient health and well-being, including quality of life metrics.
ADHD 360 is an innovative, evidence-based digital healthcare service in the UK. Being the largest virtual healthcare service in the United Kingdom, it specializes in the diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). ADHD 360 aimed to tackle persistent challenges in delivering accessible, consistent, and high-quality care.
ADHD 360 incorporated QbCheck, a standardized, objective, and remote ADHD assessment tool, into its clinical workflow. The integration aimed to reduce reliance on subjective symptom reporting, enhance diagnostic accuracy, and optimize clinician time without compromising assessment quality. Given the necessity for robust, efficient, and scalable assessment workflows, clinicians used QbCheck to collect objective symptom data remotely. This provided them with quantifiable metrics to inform diagnostic interviews and subsequent treatment planning.
Robert Nolen, Ragini Sanyal, Simon Larsson, Núria Casals, Tom Murdoch,
Rebecca Whelan, Mikkel Hansen, Phil Anderton
